Close

Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance

February 1, 2018 6:46 AM EST

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.

GUIDANCE:

Quest Diagnostics sees FY2018 EPS of $6.50-$6.70, versus the consensus of $6.61.

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings